Home / Health / Childhood cancer survivor runs half marathon at 35
Childhood cancer survivor runs half marathon at 35
29 Mar
Summary
- Diagnosed with neuroblastoma at four months old, with a poor prognosis.
- Successfully treated with Doxorubicin in a groundbreaking clinical trial.
- Now 35, she is participating in a half marathon race.
Diagnosed with neuroblastoma at just four months old, Elizabeth Rees-Gilbert faced a grim prognosis, with doctors warning she might not reach her first birthday. Her parents opted for a groundbreaking clinical trial at Birmingham Children's Hospital, which utilized the drug Doxorubicin to treat her nervous system.
The treatment proved successful, allowing Elizabeth to survive her first year and beyond. However, the therapy severely weakened her immune system, leading to a bout of pneumonia that required her to be placed on a ventilator. Despite this, she recovered and remained under hospital care until age 16.
Now 35, Elizabeth is a testament to the trial's success, enjoying a healthy life and participating in a half marathon. This event highlights her remarkable recovery and resilience. She finds inspiration in quotes and hopes her journey offers comfort to other families facing similar challenges.
